Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets.

Andrea ConaDaniele TesoroMargherita ChiamentiEsther MerliniDaris FerrariAntonio MartiCarla CodecàGiuseppe AnconaCamilla TincatiAntonella d'Arminio MonforteGiulia Carla Marchetti

Published in: BMC infectious diseases (2019)

We hereby describe a severe form of disseminated CMV disease after R-bendamustine treatment. Our observations strongly support the careful clinical monitoring of CMV reactivation/infection in oncologic patients undergoing this therapeutic regimen.

Keyphrases

patients undergoing
epstein barr virus
early onset
prostate cancer
combination therapy
replacement therapy
minimally invasive